Xenon Pharmaceuticals (XENE)

• Market cap: $3B
• 1 day: 1.02%
• 5 days: -0.1%
• 1 month: -2.98%
• 3 months: 13.75%
• 6 months: 8.23%
• Year to date: -3.41%
• 1 year: -11.96%
• 5 years: 250.18%
• 10 years: 392.39%
• Sector: Healthcare
• Industry: Biotechnology

About: Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Employees: 327